Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2025-12-25 @ 2:00 AM
NCT ID:
NCT04001894
Eligibility Criteria:
Inclusion Criteria:•
* Aged ≥18 years
* Subjects had documented with stable CAD
* Women were required to be postmenopausal or surgically sterile
* Patients were required to discontinue clopidogrel or ticagrelor at least 14 days before randomization
* Patients were required to discontinue aspirin at least 14 days before randomization.
Exclusion Criteria:
* Acute coronary syndrome
* Planned use of glycoprotein IIb/IIIa receptor inhibitors, adenosine diphosphate (ADP) receptor antagonists other than the study medication, or anticoagulant therapy during the study period
* Platelet count \<10×10\^4/μL
* Hstory of bleeding tendency
* Diagnosed as respiratory or circulatory instability
* Allergy to ticagrelor or clopidogrel
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04001894
Study Brief:
Protocol Section:
NCT04001894